Results 21 to 30 of about 84,927 (166)

Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization

open access: yesBMC Gastroenterology
Background Skeletal muscle index (SMI) is a commonly used research method for evaluating muscle mass.However, its impact on post-embolization syndrome(PES) of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE ...
Xiaojuan Wang   +9 more
doaj   +1 more source

The peculiarities of macroscopic status of the upper gastrointestinal tract mucosa in patients with hepatic and extrahepatic portal hypertension.

open access: yesMedičnì Perspektivi, 2018
Identification of endoscopic signs of concomitant pathology of the upper gastrointestinal tract allows to determine the tactics of managing patients with different forms of portal hypertension (PG).
Yu. M. Stepanov   +2 more
doaj   +1 more source

Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study

open access: yesPortal Hypertension & Cirrhosis, 2023
Aim Patients with chronic liver disease (CLD), especially cirrhosis, are at a high risk of severe illness or death from coronavirus disease‐2019 (COVID‐19) and may have a suboptimal immune response to the severe acute respiratory syndrome coronavirus 2 ...
Jitao Wang   +24 more
doaj   +1 more source

Difficulties of differential diagnosis of portal hypertension: case report

open access: yesМедицинский совет, 2021
In the article we analysed the difficulties of differential diagnosis of portal hypertension, considers a clinical case that illustrates the presented theoretical material.
T. V. Penkina   +7 more
doaj   +1 more source

National Consensus on Portal Hypertension Management in Indonesia

open access: yesActa Medica Indonesiana, 2022
Portal hypertension is a clinical syndrome that consists of hypersplenism, ascites, gastroesophageal varices, and encephalopathy. This condition is marked by increased portal pressure gradient and may occur with or without liver cirrhosis.
Juferdy Kurniawan   +7 more
doaj   +2 more sources

Research Progress of Noninvasive Evaluation of Portal Hypertension by Blood‐Based Tests

open access: yesPortal Hypertension & Cirrhosis
Portal hypertension (PH) is a collection of clinical conditions that occur due to an enduring elevation of pressure within the portal venous system, and it is closely linked to the prognosis of liver disease patients. The hepatic venous pressure gradient
Wei Chen   +10 more
doaj   +1 more source

Non-cirrhotic portal fibrosis

open access: yesInternational Journal of Advanced Medical and Health Research, 2014
Portal hypertension occurs commonly in patients with cirrhosis and rarely in those without cirrhosis of liver. The two most important causes of non-cirrhotic portal hypertension are non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous ...
Venkatesan Mukta   +2 more
doaj   +1 more source

Whole-course management of interventional treatment in liver cancer patients with portal hypertension

open access: yesJournal of Interventional Medicine, 2019
Primary liver cancer often occurs in patients with hepatitis and cirrhosis. Some patients have portal hypertension due to cirrhosis, and present with varying degrees of collateral circulation, splenomegaly and hypersplenism, ascites, and liver ...
Zhenkang Qiu, Gui Song Wang, Fei Gao
doaj   +1 more source

Application of Ultrasound Elastography in Assessing Portal Hypertension

open access: yesDiagnostics, 2022
Portal hypertension is a common manifestation in late-to-end-stage liver diseases and can cause severe complications such as ascites, hepatic encephalopathy, etc.
Man Zhang   +10 more
doaj   +1 more source

Features of encephalopathy diagnosis in patients with portal hypertension syndrome

open access: yesGastroenterologìa, 2017
Background. Hepatic encephalopathy is a pathological change in the brain functions of non-inflammatory origin, which is manifested by a syndrome of secondary neurological and cognitive disorders caused by a set of deep metabolic disorders, as a result of
Yu.M. Stepanov   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy